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How ICOS signaling causes the induction
of BCL6 leading to Tfh cell differentiation
is incompletely understood. Hedrick and
colleagues show that ICOS signaling
transiently inactivates FOXO1, which in
turn relieves FOXO1-dependent inhibition
of BCL6 expression and Tfh
differentiation. In contrast, FOXO1
promotes late-stage germinal center-Tfh
cell differentiation.
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T follicular helper (Tfh) cells are essential in the induc-
tion of high-affinity, class-switched antibodies. The
differentiation of Tfh cells is a multi-step process
that depends upon the co-receptor ICOS and the
activation of phosphoinositide-3 kinase leading to
the expression of key Tfh cell genes. We report that
ICOS signaling inactivates the transcription factor
FOXO1, and a Foxo1 genetic deletion allowed for
generation of Tfh cells with reduced dependence
on ICOS ligand. Conversely, enforced nuclear locali-
zation of FOXO1 inhibited Tfh cell development even
though ICOS was overexpressed. FOXO1 regulated
Tfh cell differentiation through a broad program of
gene expression exemplified by its negative regula-
tion of Bcl6. Final differentiation to germinal center
Tfh cells (GC-Tfh) was instead FOXO1 dependent
as the Foxo1/GC-Tfh cell population was substan-
tially reduced. We propose that ICOS signaling
transiently inactivates FOXO1 to initiate a Tfh cell
contingency that is completed in a FOXO1-depen-
dent manner.
INTRODUCTION
The generation of high-affinity antibodies requires naive CD4+
T cells to sequentially be activated, proliferate and differentiate,
acquire proximity to the B cell follicles, and provide B cells with
‘‘help’’ in the form of antigen-specific interactions, co-receptor
binding, and cytokine signaling. These specialized CD4 cells
have been termed T follicular helper (Tfh) cells, and they
are essential to promote the germinal center (GC) reaction
including B cell expansion, class switching, selection, and devel-
opment of high-affinity antibody-forming cells (Liu et al., 2013;
Crotty, 2014; Ueno et al., 2015). In the past several years,
much has been learned about Tfh cell differentiation; however,the cellular programming leading to this state remains incom-
pletely understood.
Inducible T cell co-stimulator (ICOS) is a potent co-receptor
distinct from CD28 that is induced on activated T cells and highly
expressed on Tfh cells. ICOS signaling is necessary for complete
GC development, T cell-dependent B cell help, and antibody
class switching (Vinuesa et al., 2005), and this is due to a role
for ICOS in the differentiation of activated T cells to Tfh cells
(Ueno et al., 2015).
Tfh cell differentiation is a multi-step process that begins with
dendritic cell priming and further requires B cells for additional
differentiation and maintenance (Crotty, 2014; Ueno et al.,
2015). The initial dendritic cell priming is sufficient to induce a
CXCR5+BCL6+ Tfh cell, and this was found to be dependent
on ICOS signaling (Qi et al., 2014). However, further ICOSL stim-
ulation from B cells is required for the final differentiation and
maintenance of GC-Tfh cells (Pepper et al., 2011; Crotty,
2014), and this is consistent with studies showing that ICOS is
able to influence homing to GCs through the induction of
filopodia (Franko and Levine, 2009; Xu et al., 2013). Signal trans-
duction through ICOS results in the potent activation of
phosphoinositide-3 kinase (PI3K), and this is a key event in Tfh
differentiation (Rolf et al., 2010b). In a manner not yet under-
stood, this leads to increased expression of BCL6, which has
been described as an essential transcription factor for the differ-
entiation and function of Tfh cells (Choi et al., 2013).
A major pathway downstream of PI3K signaling is the AKT-
mediated inactivation of FOXO family transcription factors.
AKT mediates the triple phosphorylation of FOXO proteins
causing their nuclear egress (Calnan and Brunet, 2008). FOXO
transcription factors are important for the expression of cyclin-
dependent kinase inhibitors and proapoptotic molecules, and
thus their inhibition is an essential aspect of growth factor-
mediated cell-cycle progression and survival. In T cells, FOXO
transcription factors have been shown to regulate multiple,
specialized functions including the expression of the Il7ra and
Klf2—control points for T cell survival and homing (Ouyang and
Li, 2011; Hedrick et al., 2012). In addition, mice with a T cell-spe-
cific deletion of Foxo1 lack functional FOXP3+ Treg cells and
spontaneously develop systemic autoimmunity. We previouslyImmunity 42, 239–251, February 17, 2015 ª2015 Elsevier Inc. 239
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Figure 1. Loss of FOXO1 Amplifies Tfh Differentiation
(A and B) WT or Foxo1TKO OTII cells were transferred into CD45.1 hosts, immunized with OVA plus adjuvant, and spleen cells were analyzed days 4 post
immunization. (A) The percentages of CXCR5lo, CXCR5int, and CXCR5hiBCL6+ cells (left) or PD1 expression (right) were determined by flow cytometry and (B) The
numbers of each cell type in the spleen were calculated, representative of two independent experiments.
(C) Adoptive transfer similar to (A) above were carried out with Foxo1KO OTII cells and the percentages of WT or Foxo1KO CXCR5lo, CXCR5int, and CXCR5hiBCL6+
cells were determined days 4 post immunization.
(D) Expression of CXCR5, BCL6, and PD1 from WT (filled histogram) or Foxo1KO (open histogram) CXCR5int OTII cells days 4 post immunization (n = 3).
Representative of two independent experiments.
(legend continued on next page)
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noted that thesemice accumulate a large population of Tfh cells,
formGCs, and produce circulating, anti-DNA antibodies, and we
proposed that the PI3K-AKT-FOXO1 signaling pathway controls
lineage commitment that, in part, specifies the Treg versus Tfh
alternative cell fates (Kerdiles et al., 2010; Hedrick et al., 2012).
Though provocative, these experiments highlight a necessity to
study the role of FOXO transcription factors in T cell differentia-
tion without the complications of autoimmunity caused by an
insufficiency of Treg cells. In support of this idea, a report
recently appeared showing that the ubiquitin ligase, ITCH, facil-
itates Tfh differentiation, and indeed it appears to act through the
degradation of FOXO1 (Xiao et al., 2014). Here, we test the prop-
osition that ICOS signaling acts to initiate a program of Tfh differ-
entiation through inhibition of FOXO1 and the resulting effects on
gene expression. Specifically, the deletion of Foxo1 results in
enhanced BCL6 expression and exaggerated differentiation of
Tfh cells.
RESULTS
Loss of FOXO1 Amplifies Tfh Differentiation
In accord with the high prevalence of Tfh cells in mice with a
T cell-specific Foxo1 deletion (Kerdiles et al., 2010), we tested
whether ICOS-mediated FOXO1 inactivation constitutes an
important step in Tfh cell differentiation. As such, we adoptively
transferred Foxo1f/fCd4Cre+CD45.2+ (Foxo1TKO) OTII or
Foxo1f/fCD45.2+ (wild type, WT) OTII cells into CD45.1 mice. In
this and subsequent experiments, the starting population was
depleted of CD25+CD69+ cells prior to transfer. Host mice
were then immunized with OVA plus adjuvant. Four days post-
immunization WT and Foxo1TKO OTII cells were fully activated
as determined by CD44 expression (data not shown), and the
WT OTII cells differentiated into three cell populations:
CXCR5loBCL6lo cells, described as T effector (Teff) cells;
CXCR5int cells, Tfh cells; and CXCR5hiBCL6hi T cells that are
destined to be GC-Tfh cells (Pepper et al., 2011; Liu et al.,
2013). By contrast, almost all Foxo1TKO OTII cells displayed
CXCR5int expression characteristic of Tfh cells (Figure 1A).
Consistent with this, PD1 expression was also elevated in
Foxo1TKO compared to WT T cells (Figure 1A).
Contrary to expectations given the role of FOXO transcription
factors in the expression of Bim and Fas-ligand (Calnan
and Brunet, 2008; Fu and Tindall, 2008), there was a
decrease in the total number of Foxo1TKO T cells compared
with WT (Figure S1A). The analysis of cultured T cells showed
that this defect in accumulation was not due to retarded cell
division, but rather, increased apoptosis (Figure S1B–1F). It is
cell-intrinsic (Figure S1D), and could be completely rescued by
the addition of a pan-caspase inhibitor (Figure S1F). Although
activation via interleukin-2 (IL-2) or a superantigen leads to
FOXO1 inactivation (Stahl et al., 2002; Fabre et al., 2005), an
important point is that this inactivation was transient, such that
at least by 24 hr post-activation, FOXO1 contributed to CD4+
T cell survival.(E) Analysis of CXCR5 versus BCL6 expression ofWT Foxo1KO cells 4 days post inf
MFI (Right). p < 0.01 for all three parameters. Data is representative of two indiv
(F) Expression of CCR7, CD62L, and PSGL1 on WT or Foxo1KO OTII cells days 4 p
individual experiments.All three populations were reduced with a Foxo1 deletion,
although the decrease was minimal for Tfh (CXCR5int) cells (Fig-
ure 1B). IL-7 is required for naive T cell survival and normal
expression of BCL2 in naive T cells, and it increases Tfh cell dif-
ferentiation (Surh and Sprent, 2008; Seo et al., 2014). As Foxo1-
deficient naive cells have reduced expression of IL-7Ra (Kerdiles
et al., 2009), we determined whether enforced expression of Il7ra
(Yu et al., 2004) would rescue survival or alter the course of the
response. Results showed no effect of Il7ra expression on the
proportion or number of Foxo1TKO cells that became Tfh cells
(Kerdiles et al., 2010; data not shown).
A Foxo1 loss of function was further tested by acute deletion
just prior to immunization. After treatment with tamoxifen,
T cells were harvested from Foxo1f/f Rosa26Cre-ERT2 OTII
(Foxo1KO) and Rosa26Cre-ERT2 OTII mice (WT) (Kerdiles et al.,
2009) and transferred into naive hosts. The starting and unimmu-
nized OTII populations from these mice were equivalent for the
expression of CD44 and CXCR5 (Figure S1G and data not
shown). Notably, the proportion of Foxo1KO OTII cells that ac-
quired a CD44hi activated phenotype day 4 post immunization
was equivalent to WT, and yet similar to Foxo1TKO T cells, nearly
all Foxo1KO OTII cells displayed a CXCR5int phenotype (Figures
1C and S1G). Similar to Foxo1TKO T cells, further analysis of
this CXCR5int Tfh subset revealed higher expression of
CXCR5, BCL6, and PD1 in Foxo1KO cells compared with the
equivalent WT CXCR5int population (Figures 1D and S1H).
To determine whether these effects applied to other immuni-
zation conditions, we analyzed the response to infection with
Listeria monocytogenes. After adoptive transfer of OTII cells,
host mice were infected with actA-deficient Listeria monocyto-
genes (DActA-Lm) expressing OVA (Ertelt et al., 2009), and the
analysis day 4 post infection revealed that virtually all the
Foxo1KO OTII cells were CXCR5+ (Figure 1E). Again, within
the CXCR5+ population, Foxo1KO T cells were uniformly higher
by approximately two-fold for the expression of CXCR5, BCL6,
and PD1 (Figure 1E).
A defining characteristic of Tfh cells is location within the B cell
follicles, whereas the eponymous GC-Tfh cells are located within
GCs. To analyze the role of FOXO1 in localization, we determined
the expression of homing molecules in addition to CXCR5. As
expected, based on the control of Klf2 by FOXO1 (Fabre et al.,
2008; Kerdiles et al., 2009), virtually all Foxo1KO OTII cells were
CD62L 4 days post immunization, whereas the WT T cells dis-
played heterogeneous expression (Figure 1F). CCR7 expression
was unchanged with respect to activated WT T cells, but a pro-
portion of the Foxo1KO OTII cells were low for PSGL1 (Figure 1F),
a phenotype that allows T cells to exit the T cell zone (Crotty,
2014). Combined with the expression of CXCR5 (e.g., Figure 1D),
Foxo1KOOTII cells appear to express a repertoire of homingmol-
ecules that would promote homing to B cell areas of the spleen
(Crotty, 2014).
WT or Foxo1KOOTII T cells were directly examined 4 days after
immunization by immunohistology. WT OTII cells were mostly
found within the splenic T cell zone including some cells alongectionwithDActA-Lm expressingOVA (Left). Plots showCXCR5, BCL6, or PD1
idual experiments.
ost immunization is shown (n = 3–4). Data are representative from at least two
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the T cell-B cell border. In contrast, a larger proportion of the
Foxo1KO OTII cells was found in the follicle with relatively few
cells found deep within the T cell zone (Figure S1I). However,
we note that the Foxo1KO cells were also not found deep in the
B cell follicle.
The Regulation FOXO1 and ICOS Is Coupled via a
Negative Feedback Loop
To analyze the relationship between ICOS signaling and FOXO1,
we tested whether ICOS signaling would inactivate FOXO1 via
nuclear egress (Calnan and Brunet, 2008). Naive CD4+ T cells ex-
pressing a FOXO1-GFP fusion protein were activated for 48 hr
under iTfh conditions, rested for 24 hr, and restimulated for
30min with antibody specific for CD3 in the presence or absence
of agonist ICOS-specific antibody. At 30 min post restimulation
there was no difference in the amount of FOXO1-GFP in live cells
(Figure 2A, left). However, upon restimulation through CD3 and
ICOS, but not CD3 alone, the similarity score (ImageStream anal-
ysis) for DRAQ5 (nucleus) and FOXO1-GFP was reduced; this
corresponds with reduced co-localization and nuclear FOXO1
(Figure 2A, middle). In agreement, there was an increased per-
centage of cells stimulated through ICOS that displayed
FOXO1-GFP exclusively in the cytoplasm (Figure 2A, right).
However, at 24 hr post restimulation through CD3 and ICOS,
the amount of FOXO1-GFP was increased with little difference
in the DRAQ5, FOXO1-GFP similarity score (Figure 2B, left, mid-
dle). Consistent with these results, nuclear intensity of FOXO1-
GFP was not diminished in live cells 24 hr post-restimulation
through CD3 and ICOS (Figure 2B, right). These observations
show nuclear FOXO1, which was lost at 30 mim post-activation,
was reestablished by 24 hr.
FOXO transcription factors have been shown to positively
regulate the transcription of growth factor receptors (e. g., IL-
7Ra, insulin receptor) that, in turn, signal through PI3K to cause
FOXO inactivation (Hedrick, 2009; Kerdiles et al., 2009). This cre-
ates a negative feedback loop. Activation through CD3 and
CD28 induced ICOS expression in WT T cells, and this induction
was attenuated in Foxo1KO T cells (Figure 2C, left). Because
ICOS signaling also inactivated FOXO1, how is ICOSmaintained
in differentiating Tfh cells? To examine this, we further measured
ICOS expression in iTfh cultures and found that ICOSwas super-
induced in WT T cells consistent with the phenotype of Tfh cells,
and its expression became relatively less FOXO1 dependent
(Figure 2C, right). Foxo1KO T cells cultured in iTfh conditions
expressed an amount of ICOS at least equivalent to WT
T cells co-stimulated through CD28. A conclusion is that
although ICOS could be potentially subject to negative feedback
regulation, there are two ways in which this is tempered. One,
ICOS-mediated FOXO1 inactivation is transient (Figures 2A
and 2B), and two, FOXO1 dependence is reduced under iTfh
conditions (Figure 2C, right). In vivo activation also revealed
ICOS induction compared with naive T cells, and its expression
was progressively higher comparing Teff (CXCR5lo), Tfh cells
(CXCR5int) and GC-Tfh (CXCR5hiBCL6hi) cells. In all three sub-
sets, the ICOS induction was partially dependent upon FOXO1
(Figure 2D).
The results suggested the possibility that FOXO1 directly reg-
ulates Icos expression. To analyze FOXO1 chromosomal binding
in naive T cells, we carried out a whole-genome scan for FOXO1242 Immunity 42, 239–251, February 17, 2015 ª2015 Elsevier Inc.binding sites in CD4 T cells (ChIP-seq) (Hess Michelini et al.,
2013). Accuracy of the analysis was verified by an examination
of the average tags per position, genomic GC content, and the
distribution of peaks between regions of the genome (Figure 2E).
The most frequent binding site corresponded with the known
FOXO-DAF16 consensus site (Figure 2E) (Hedrick et al., 2012).
In addition, the analysis pinpointed binding sites in the Il7r and
Ctla4 genes we have previously identified as evolutionarily
conserved and bound by FOXO1 (Kerdiles et al., 2009; Kerdiles
et al., 2010) (Figure S2A). These data further revealed that in CD4
T cells, FOXO1 is bound to an evolutionarily conserved FOXO
consensus binding site in the Icos promoter (Figures 2F and
S2B) and remains bound after activation for 48 hr (Figure 2G).
Thus, similar to Il7ra and Ctla4, Icos expression is dependent
in part on FOXO1, and the Icos gene is bound by FOXO1 at an
evolutionarily conserved promotor binding site.
Tfh Cell Differentiation in the Absence of FOXO1 Is
Independent of ICOSL
FOXO1-deficient T cells have diminished expression of ICOS,
and yet exhibit enhanced Tfh differentiation. This, combined
with the ICOS-dependent inactivation of FOXO1 suggested
that genetic ablation of FOXO1 would promote ICOS-indepen-
dent Tfh differentiation. To test this, we analyzed the depen-
dence of Tfh differentiation on ICOSL in two ways. In one set
of experiments, we transferredWT or Foxo1KO T cells in the pres-
ence or absence of antibodies specific for ICOSL. In a second
set of experiments, we transferred T cells into WT or ICOSL/
hosts. In these experiments, the results were similar. Although
the presence of WT Tfh cells displayed a strong dependence
on ICOSL recognition, this dependence was greatly reduced
for Foxo1KO T cells (Figure 3A–3D). Importantly, in both experi-
mental models, the number of Foxo1KO CXCR5+ OTII cells was
substantially greater than the number of WT CXCR5+ cells under
these conditions (Figures 3B and 3D). In particular, although the
differentiation of WT cells was virtually lost in Icosl/ hosts (Fig-
ures 3C and 3D) (Choi et al., 2011; Pepper et al., 2011), in the
absence of FOXO1 the mean number of CXCR5+ T cells was
increased by 10-fold over WT controls (Figure 3D). Further ex-
periments showed that CXCR4 induction, shown to have a strin-
gent requirement for ICOS in WT T cells (Odegard et al., 2008)
was induced in Foxo1KO T cells in an ICOS-independent manner
(Figures S3A and S3B). From these data, we conclude that loss
of FOXO1 facilitates differentiation into Tfh cells with a greatly
diminished requirement for ICOS signaling, i.e. FOXO1 inactiva-
tion is epistatic to ICOS expression and signaling.
Loss of FOXO1 Promotes B Cell Help and Anti-DNA
Antibodies in the Absence of ICOS
To determine whether loss of Foxo1 could complement a loss of
Icos, we bred Foxo1TKO with Icos/ mice and analyzed the pro-
portion of CXCR5+PD1+ cells from each of four genotypes. To
account for the increase in activated CD4 cells in the Foxo1TKO
mice and the reduced population of activated cells in Icos/
mice (Odegard et al., 2008; Kerdiles et al., 2010), we focused
on the activated CD4+ (CD44hi) population. In addition, we
enumerated class-switched and GC B cells. For each of these
parameters, the deficiencies displayed by Icos/ mice were
all or partially rescued by the inclusion of the Foxo1TKO alleles
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Figure 2. The Regulation FOXO1 and ICOS Is Coupled via a Negative Feedback Loop
(A) Plots show MFI of FOXO1-GFP (left), similarity score between DRAQ5 and FOXO1-GFP (Middle), and the percent of cells with FOXO1-GFP exclusively in the
cytoplasm (right) 30 min post restimulation through CD3 and ICOS. None indicates the cells were not restimulated. Data are representative of two independent
experiments.
(B) Plots show MFI of total FOXO1-GFP (left), similarity score between DRAQ5 and FOXO1-GFP (middle), and intensity of FOXO1-GFP overlapping with the
nuclear mask (right) 24 hr post restimulation.
(C) ICOS expression onWT or Foxo1KO CD4 cells activated in vitro for 72 hr via CD3 andCD28 in the presence or absence of iTfh conditions. The histograms show
the expression of ICOS on cells activated with anti-CD3 and anti-CD28 without the addition of exogenous cytokines (left). Data are representative of two in-
dependent experiments.
(D) Histograms depict ICOS expression on CXCR5lo, CXCR5int, or CXCR5hiBCL6+ from WT or Foxo1KO OTII cells days 4 post immunization. Data are repre-
sentative of two independent experiments.
(E) Analysis of FOXO1-specific ChIP-Seq of naive CD4 T cells. The most frequent consensus binding site was determined to be TGTTTAC, the size of the
nucleotide in the graphic corresponds with its frequency.
(F) The Icos locus is shown for FOXO1-specific ChIP-seq (top track) (see also Figure S2B), and the centrally positioned nucleotide sequence within the promoter
peak is listed. The bottom track shows mammalian sequence conservation (UCSC Genome Browser).
(G) FOXO1-specific ChIP of Icos locus from WT CD4 T cells activated in vitro.(Figures 4A–4C). Although little to no immunoglobulin G (IgG) iso-
type anti-DNA antibodies were detected in the Icos/mice, sig-
nificant titers were measured in DKO mice (Figure 4D, left). DKO
mice also had significantly higher levels of total IgG levels in the
sera than Icos/ mice (Figure 4D, right). The presence of GCs
and isotype switched antibodies was not simply due to a lack
of regulatory FOXP3+ Tfh (TFR) cells, beacuse the frequency of
the CXCR5+ Tfr population within the Treg population was not
reduced with the deletion of Foxo1 (Figure 4E). These data indi-cate that deletion of Foxo1 in T cells is sufficient to allow differ-
entiation of a Tfh-like cell in the absence of ICOS, and these cells
cooperate with B cells to produce isotype-switched, anti-DNA
antibodies—at least in the absence of effective Treg cells.
FOXO1 Negatively Regulates BCL6 Expression
If the loss of FOXO1 is important for Tfh differentiation, then a
prediction is that FOXO1 inhibition as a consequence of ICOS
signaling will facilitate the induction of BCL6 expression (ChoiImmunity 42, 239–251, February 17, 2015 ª2015 Elsevier Inc. 243
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Figure 3. Tfh Differentiation in the Absence
of FOXO1 Is Independent of ICOSL
(A and B)WT or Foxo1KOOTII cells were transferred
into CD45.1 hosts and mice were immunized with
OVA plus adjuvant. Where indicated, mice were
treated with blocking anti-ICOSL. (A) The percent-
ages of CXCR5lo, CXCR5int, and CXCR5hiBCL6+
cells and (B) total number of CXCR5+ (including
both the CXCR5int and CXCR5hi populations) of WT
or Foxo1KO OTII cells is shown. One of four repre-
sentative experiments.
(C) The percentages of CXCR5lo, CXCR5int, and
CXCR5hiBCL6+ cells of WT or Foxo1KO OTII cells in
WT or Icosl/ hosts days 4 post immunization.
Data are representative of two independent ex-
periments.
(D) Numbers of WT or Foxo1KO CXCR5+ (including
both the CXCR5int and CXCR5hi populations) OTII
cells days 4 post immunization from WT or Icosl/
hosts plotted on a log scale. Data are pooled from
two independent experiments.et al., 2011). In naive cells, the low amount of BCL6 detected was
unchanged between WT and Foxo1KO mice (data not shown).
T cells were activated for 48 hr under iTfh conditions, and they
were rested for 24 hr and re-stimulated with or without ICOS-
specific antibody for a further 24 hr. Restimulation through
ICOS increased BCL6 expression, whereas it was substantially
higher in Foxo1KO T cells compared with WT T cells under all
conditions (Figure 5A). In particular, Foxo1KO T cells re-stimu-
lated through CD3 alone expressed more BCL6 than WT
T cells stimulated through CD3 and ICOS. There was a further in-
duction of BCL6 in the Foxo1KO T cells stimulated through ICOS
(compare anti-CD3 with anti-CD3 plus anti-ICOS), and this sug-
gests that an additional pathway downstreamof ICOSmight play
a role in BCL6 induction. Similar to protein expression, WT Bcl6
RNA increased upon restimulation in the presence of anti-ICOS,244 Immunity 42, 239–251, February 17, 2015 ª2015 Elsevier Inc.and it was expressed in higher amounts in
Foxo1KO cells compared to WT cells (Fig-
ure 5B). Furthermore, this increase in
BCL6 was cell-intrinsic (Figure 5C), and it
was not secondary to selective death of
Foxo1KO T cells (Figure S4A).
Analysis of FOXO1 binding byChIP-Seq
in naive CD4 T cells showed that FOXO1 is
exclusively bound to the Bcl6 locus at the
boundary of the first (38 bp) non-coding
exon and the first intron (Figures 5D and
S4B). This region includes tandem se-
quences separated by 30 bases that are
very similar to the conserved FOXO1
consensus site (Figures 5D and S4B),
and we have also found this peak in naive
and activated CD8 T cell data sets
(data not shown). This region is highly
conserved between mice and human be-
ings and this conservation extends to a
comparison of marsupials and eutherian
mammals, implying evolutionary selection
for at least 130 million years (Figure S4C).FOXO1 binding to this site in naive T cells was confirmed by
ChIP analysis (Figure 5E). We further examined whether
FOXO1 binding is lost under conditions of T cell stimulation. After
48 hr of iTfh activation, cells were rested for 24 hr and tested
(None), or re-stimulated through CD3 and ICOS for 1 hr or
24 hr. As shown, FOXO1 was bound to this site in T cells acti-
vated under iTfh conditions, but it was reduced upon restimula-
tion with through CD3 and ICOS (Figure 5F). This is consistent
with the initially reduced nuclear localization of FOXO1 (Fig-
ure 2A). However, nuclear FOXO1 is not decreased 24 hr post-
restimulation through CD3 and ICOS (Figure 2B), and yet binding
of FOXO1 to Bcl6 was still reduced (Figure 5F). These data are
consistent with FOXO1 binding to the Bcl6 gene and mediating
transcriptional repression that is relieved upon ICOS signaling;
however, we lack direct evidence for transcription repression
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Figure 4. Loss of FOXO1 Promotes B Cell Help and Antibodies in the
Absence of ICOS
(A) The percentage of LN CD4+CD44hi cells expressing CXCR5 and PD1 is
shown from WT; Foxo1TKO; Icos/; and DKO. Data are representative of four
independent experiments.
(B and C) The percentages of isotype switched (IgMIgD) (B) and GC
(GL7+CD95+) (C) B cells present are shown. Comparing WT and Foxo1TKO or
Icos/ and DKO p < 0.01. Data are representative of four independent ex-
periments.that might include germline mutations in the tandem FOXO1
binding sites.
Further analysis of the 4333 FOXO1 genomic binding sites re-
vealed many genes involved in Tfh differentiation located within
close proximity. Inspection of Cxcr5, Batf, Ccr7, Cxcr4, Irf4,
Selplg (P-selectin ligand-CD162), and Maf loci revealed one or
more strong FOXO1 binding sites located near the transcrip-
tional start site or within several kilobases (Figure S5). The
exception wasMaf, which is functionally important for terminally
differentiated GC-Tfh cells (Liu et al., 2013).
Enforced Nuclear Localization of FOXO1 Prevents Tfh
Differentiation
If FOXO1 inactivation is required for Tfh differentiation, enforced
nuclear localized would be predicted to block the appearance of
Tfh cells. To test this, we transduced T cells from OTII Foxo1AAA
mice with a Hit and Run CRE recombinase retrovirus and adop-
tively transferred them (Silver and Livingston, 2001; Ouyang
et al., 2012). After immunization, Foxo1AAA T cells expressed
CD44+ (data not shown) and displayed superinduction of ICOS
(Figure 6A) consistent with the importance of FOXO1 in the regu-
lation of the Icos gene. Despite this, Foxo1AAA T cells displayed a
reduced ability to differentiate into the Tfh phenotype as
compared to WT (Figure 6B). The accumulation of Foxo1AAA
T cells was also reduced (data not shown), and the origin of
this defect is a topic of further investigation.
Foxo1KO T Cells Have Reduced Ability to Differentiate
into GC-Tfh Cells
To characterize the role of FOXO1 in GC-Tfh differentiation, we
examined a polyclonal response to L. monocytogenes. For
this, we generated mixed WT:Foxo1TKO bone-marrow chimeras
(Kerdiles et al., 2010). Mice were infected with DActA-Lm, and at
day 9 the CXCR5int (and total CXCR5+ cells) cells were overrep-
resented within the Foxo1TKO population compared with WT
cells. Surprisingly there was a notable paucity of Foxo1TKO
CXCR5hiBCL6hi GC-Tfh cells (Figure 7A).
Studies have shown that MAF is an important transcription
factor in Tfh development, and in particular, it might be essential
for IL-4 expression associated with GC-Tfh cells (Liu et al., 2013;
Crotty, 2014; Ueno et al., 2015). Consistent with this, analysis of
WT OTII T cells 4 days after activation in vivo revealed that only
the CXCR5hi PD1hi subset expressed high amounts of MAF (Fig-
ure 7B), and this was abrogated by treatment of the mice with
anti-ICOSL (Figure 7C). Compatible with the lack of a BCL6hi
population at GC time points, Foxo1KO T cells were selectively
deficient in theMAF+ population at both day 4 and day 7 post im-
munization (Figure 7D). In addition, Foxo1KO OTII T cells did not
give rise to CXCR5hiBCL6hi or CXCR5hiPD1hi cells day 7 post im-
munization (Figure 7E), and at this time, FOXO1 is consistently
expressed (Figure 7F). Similar results were found following infec-
tion with VSV-OVA (Figures 7G and 7H). In sum, these data show(D) Plot shows relative amounts of IgG anti-dsDNA in sera. Data are repre-
sentative of three independent experiments (left). The levels of total IgG in sera
are plotted. Data shown are pooled from two experiments (right).
(E) Plots show the percentage of CXCR5+ TFR cells within LN Treg (CD4
+
FOXP3+) population for each genotype. Data shown are from one of two in-
dependent experiments.
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Figure 5. FOXO1 Negatively Regulates BCL6 Expression
(A and B) WT or Foxo1KO naive CD4 cells activated under iTfh conditions, rested, and then restimulated via CD3 with or without antibody specific for ICOS.
(A) BCL6 levels determined by flow cytometry. None indicates the cells were not restimulated, and the MFI is shown for one example. The filled (WT) and open
(Foxo1KO) gray circles on the graph represent background staining of a control antibody for each individual biological replicate. Data are representative of three
independent experiments. (B) Bcl6 levels were determine by qPCR. Data shown are from one of two experiments.
(C) WT (CD45.1) and Foxo1KO (CD45.2) cells were co-cultured under conditions as in (A) and the MFI of WT and Foxo1KO cells from each well are shown. Gray
circles represent background staining of a control antibody. Data are representative of two individual experiments.
(D) The Bcl6 locus is shown for FOXO1-specific ChIP-Seq (top track) (see also Figure S4B), and the centrally positioned nucleotide sequences within the peak
found in the first intron are listed. The bottom track represents mammalian sequence conservation.
(E and F) FOXO1-specific ChIP of Bcl6 locus from (E) naive CD4 T cells or (F) CD4 T cells activated as in (A) and restimulated with CD3- and ICOS-specific
antibodies as in (A) for 1 hr or 24 hr. Filled bars represent percent of input of anti-FOXO1 immunoprecipitation. Open bars represent percent of input of the IgG
control. None indicates the cells were activated and rested but not restimulated. Data are representative of two independent experiments.that genetic inactivation of Foxo1 exaggerates the differentiation
of Tfh cells in an ICOS-independent manner, and yet, FOXO1
plays a role in the final differentiation to GC-Tfh cells.
DISCUSSION
Previous work established an early role for ICOS and and its acti-
vation of PI3K signaling in the differentiation of CD4 T cells into
Tfh cells, and this signaling pathway influences the induction of
key molecules including BCL6, MAF, IL-4, and IL-21 (Bauquet
et al., 2009; Gigoux et al., 2009; Rolf et al., 2010a; Choi et al.,
2011). Since the basis for PI3K regulation of cell growth and dif-
ferentiation largely emanates through AKT-mediated inhibition of
FOXO1 transcriptional activity (Calnan and Brunet, 2008), we
wished to test the idea that Foxo1 is epistatic to Icos in the elab-
oration of one or more of these Tfh characteristics. Additionally,
two recent papers suggest that reduced expression of FOXO1,246 Immunity 42, 239–251, February 17, 2015 ª2015 Elsevier Inc.either due to increased expression of ICOS induced by loss of
FOXP1, or due to ITCH-mediated degradation, may increase
Tfh differentiation (Wang et al., 2014; Xiao et al., 2014). The
studies described in this report provide a mechanism for those
findings.
Tfh cells at the B-follicular border express CXCR5 and BCL6
(Ramiscal and Vinuesa, 2013), whereas GC-Tfh cells can be
characterized by MAF expression. Here we show that deletion
of Foxo1 exaggerated the initial antigen-driven step in Tfh differ-
entiation resulting in an expanded proportion of CXCR5+ CD4
T cells localized to the border of B cell follicles. Foxo1KO
T cells were proportionately overrepresented as CXCR5int
BCL6int cells, and in addition these Tfh cells expressed amounts
of CXCR5, BCL6, PD1, and CXCR4 greater than those of the
equivalentWT Tfh populations—although not to the level charac-
teristic of GC-Tfh cells. In fact, in the absence of FOXO1, despite
the increased proportion of Tfh cells, few GC-Tfh cells emerged
A B
Figure 6. Enforced Nuclear Localization of FOXO1 Suppresses Tfh Differentiation
(A) ICOS expression or (B) the percentages of CXCR5lo, CXCR5int, and CXCR5hiPD1+ cells fromWT or Foxo1AAA OTII cells day 4 post immunization. In each case,
p < 0.001. Data are representative of two independent experiments.even as late as 9 day post DActA-Lm infection. Our conclusion is
that a transient inactivation of FOXO1 skews the contingency of
effector versus Tfh differentiation, whereas progression to
mature GC-Tfh cells is promoted by FOXO1.
We emphasize that FOXO1 inactivation is only transient. In
T cells stimulated through CD3 and ICOS, nuclear FOXO1-GFP
is reduced at 30 min but reestablished within 24 hr. Moreover,
FOXO1 is required for T cell viability as early as 24 hr post acti-
vation. Whether there are mechanisms opposing AKT signaling
or desensitizing ICOS signaling is not known; however, stress ki-
nase phosphorylations, glycosylation, or methylation have all
been shown to encourage nuclear location of FOXO factors
(Hedrick et al., 2012). This is further illustrated by regulation of
ICOS. Although FOXO1 clearly has a role for full ICOS ex-
pression, ICOS is induced early in DC-mediated antigen presen-
tation, and remains high in Tfh and GC-Tfh cells despite its
potential for signaling via PI3Kd and causing negative feedback
inactivation of FOXO1. Thus, although genetic ablations pre-
sented here and elsewhere point to an important contingency-
based inactivation of FOXO1 (Wang et al., 2014; Xiao et al.,
2014), they do not recapitulate the dynamics of FOXO1 inactiva-
tion. Furthermore, FOXO1 appears to be required for GC-Tfh dif-
ferentiation, although the mechanism of action is unknown. The
reduced expression of ICOSmight limit the ability of Foxo1KO Tfh
cells to generate filopodia, which allow for Tfh cells to home from
the T-B border to the GC (Xu et al., 2013). This possibility would
be consistent with the presence of GC-Tfh cells in Foxo1TKO
mice contrasted with the loss of Foxo1KO GC-Tfh cells in compe-
tition with WT cells. FOXO1 has also been shown to bind to the
Ifng locus and inhibit expression of IFN-g (Ouyang et al., 2012),
and thus in its absence, ectopic gene expression might subvert
GC-Tfh differentiation. The most parsimonious explanation isthat FOXO1 directly regulates the transcription of genes required
for full GC-Tfh differentiation.
A complication described here is the observation that acti-
vated Foxo1/ CD4 T cells have a reduced viability compared
to WT T cells. This raised the possibility that the increase in the
proportion of Tfh cells could be due to selective death of Teff
cells; however, the results show that this alone cannot explain
the phenotype of Foxo1/ T cells. If the exaggerated proportion
of Tfh cells were due only to preferential loss of Teff cells, then
there would be no reduction in the requirement for ICOS
signaling. In two different types of experiments we show that
Foxo1KO T cells differentiate into Tfh cells with a substantially
reduced requirement for ICOS signaling. Similarly, the induced
expression of BCL6 is an important part of the Tfh program,
and loss of FOXO1 results in the increased expression of BCL6
compared to wild-type, even when apoptosis is blocked. In a
separate line of experimentation, loss of Foxo1 genetically com-
plemented the loss of Icos in that there emerged CXCR5+PD1+
cells, GC-B cells and anti-DNA IgG antibodies. In addition, a
role for FOXO1 in Tfh differentiation is supported by the known
signaling pathway downstream of ICOS in T cells, that is, PI3K
and AKT activation (Rolf et al., 2010b), which was shown here
to result in the inactivation of FOXO1. Finally, enforced nuclear
expression of FOXO1 inhibits the differentiation Tfh cells, and
the sum of these results provide a mechanism by which ITCH-
mediated FOXO1 degradation is required for Tfh differentiation
(Xiao et al., 2014).
These results demonstrate that inactivation of FOXO1 is an
essential outcome of ICOS signaling in the contingency of CD4
T cell differentiation, and this establishes an important link in
the signaling from ICOS to the induction of Bcl6 expression. Pre-
vious studies have reported that FOXO1, FOXO3, or FOXO4Immunity 42, 239–251, February 17, 2015 ª2015 Elsevier Inc. 247
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Figure 7. FOXO1 KO T Cells Have Reduced Ability to Differentiate
into GC-Tfh Cells
(A) Mixed bone-marrow chimeras (WT-CD45.1 and Foxo1TKO) were infected
with DActA-Lm. CD4+B220-CD44hiLLO+ cells were phenotyped from each
donor. Representative of two separate experiments.
(B) MAF expression within CXCR5lo, CXCR5int, or CXCR5hiPD1hi OTII T cells
day 4 post immunization (n = 3). Representative of three independent
experiments.
(C) Percentages of CXCR5lo, CXCR5int, and CXCR5hiMAFhi subsets within
CD4+ WT OTII T cells day 4 post immunization in the presence or absence of
blocking anti-ICOSL. Representative of four host mice per condition.
(D) Analysis similar to (C) using WT or Foxo1KO OTII cells assayed at day 4
(n = 3–5) and day 7 (n = 3). One of at least two representative experiments.
248 Immunity 42, 239–251, February 17, 2015 ª2015 Elsevier Inc.binds upstream of BCL6 acting as a postive regulator in different
types of cells (Pellicano and Holyoake, 2011; Oestreich et al.,
2012), whereas we found that a Foxo1 deletion enhances
BCL6 expression. We also found, using ChIP-seq, that FOXO1
binding in naive CD4 T cells was restricted to a site at the begin-
ning of the Bcl6 first intron (also the case for naive and activated
CD8 T cells—data not shown), and we propose that FOXO1 reg-
ulates Bcl6 in T cells through transcriptional repression. Repres-
sion at this region is also associated with STAT5 competition for
STAT3 binding (Walker et al., 2013). In addition, this region of the
first BCL6 intron is often mutated in diffuse large B cell lym-
phomas (DLBCL) (Migliazza et al., 1995). The mechanisms of
Bcl6 regulation in T cells are not as well studied, although there
is evidence for contributions from STAT3, STAT5, and BATF (Liu
et al., 2013).
Combined with previous results showing that FOXO1 is
required for Treg differentiation (Kerdiles et al., 2010; Ouyang
et al., 2010), a possibility is that the extent or duration of
FOXO1 nuclear exclusion is one factor determining the fate of
antigen-activated CD4 T cells. Whether the contingency deci-
sion is simply stochastic or depends upon an undetermined var-
iable such as strength of signal (TCR peptide-MHC affinity or
avidity), concentration of free cytokines, or location, is unknown.
Nonetheless, the differential requirements for FOXO1 activity
likely explain why Tfr cells derive from tTregs and not pTregs
(Chung et al., 2011; Linterman et al., 2011). Naive T cells could
not simultaneously receive an ICOS signal and maintain
FOXO1 activity—both of which would be required for Tfr differ-
entiation from naive T cells (Hedrick et al., 2012; Sage et al.,
2013). Rather, tTregs differentiate into stable Tregs in the
thymus, and can thus receive an ICOS signal in peripheral
lymphoid organs, which might allow them to inactivate FOXO1
and further differentiate into Tfr cells.
The mechanism by which FOXO1 affects Tfh differentiation
appears to include its role in the regulation of Icos and Bcl6,
but in addition, other transcription factors that have been impli-
cated in Tfh differentiation. BATF is required for Tfh differentia-
tion and appears to directly control Bcl6 (Betz et al., 2010; Ise
et al., 2011). Within a 35 kb region of the genome that includes
only the Batf gene, there is a single and very strong FOXO1
peak (rank 411 of 4333), and this peak is located within 100 bp
upstream of the Batf TSS (Figure S5). Similarly, IRF4 is required
for Tfh differentiation (Bollig et al., 2012), and a FOXO1 binding
site was detected 1,200 bp upstream of the Irf4 TSS, and three
peaks were detected 37 kb, 43 kb, and 83 kb downstream
(rank 1578, 359, 2050 of 4333). On the other hand, other genes
important for Tfh differentiation such as Id3 and Ascl2 have no
proximal FOXO1 binding sites (Miyazaki et al., 2011; Liu et al.,(E) Plots show CXCR5 versus BCL6 (left) or CXCR5 versus PD1 (right) at day 7
post immunization. One of two representative experiments.
(F) Expression of FOXO1 in CXCR5lo, CXCR5int, and CXCR5hiBCL6+ subsets of
WT OTII cells at day 4 and day 7 post immunization.
(G) The proportions of CXCR5lo, CXCR5int, or CXCR5hiMAF+ cells at day 6 post
VSV-OVA infection from co-transferred WT and Foxo1KO OTII T cells. Data are
representative of two independent experiments.
(H) Plots show CXCR5 versus BCL6 (left) or CXCR5 versus PD1 (right)
expression from cotransferred WT or Foxo1KO OTII T cells at day 6 post
VSV-OVA infection (as in G). Data are representative of two independent
experiments.
2014). With the strong caveat that enhancers can be located up
to 1 Mb away from the transcription start site (Smallwood and
Ren, 2013), the experiments suggest that FOXO1 plays a role
in directly regulating a part of the program of gene expression
important for Tfh differentiation.
Tfh cells are known to have altered expression of homing mol-
ecules that directly control their localization into the B cell folli-
cles. In addition to increased CXCR5 expression, Tfh cells
have been shown to have increased expression of CXCR4 but
reduced expression of CCR7, CD62L, PSGL1 (encoded by
Selplg), and EBI2 (encoded by Gpr183) (Estes et al., 2004;
Hardtke et al., 2005; Poholek et al., 2010; Kroenke et al.,
2012). In accord, Foxo1KO cells displayed increased expression
of CXCR5 and CXCR4 in comparison with WT Tfh cells, but
PSGL1 and CD62L expression was decreased day 4 post
immunization. FOXO1 has also been shown to upregulate
expression of CCR7 through its control of KLF2 expression.
These results raise the possibility that loss of FOXO1 might in-
crease Tfh differentiation by controlling expression of these
homing molecules consistent with FOXO1 binding sites located
proximal to Cxcr5, Cxcr4, Ccr7, Selplg, and Gpr183.
We propose that the presence or absence of FOXO1 in the
landscape of promoters and enhancers found at early stages
of T cell activation is a key step in determining the progression
of differentiation that ultimately gives rise to one or more func-
tional T helper cell subsets. An implication of this work is that
endocrine signaling known to inactivate FOXO1 in liver, muscle,
and fat might do so as well in T cells, and thus the immune
response to an infectious agent might be skewed depending
upon the physiological condition of the host.
EXPERIMENTAL PROCEDURES
Mice
Mice were maintained in a specific-pathogen free vivarium. All experiments
were carried out in accordance to the Institutional Animal Care and Use
Committee of University of California, San Diego. Foxo1f/f, Foxo1f/fCd4Cre
(Foxo1TKO), Foxo1f/fCd4Cre OTII, and Foxo1f/fRosa26Cre-ERT2 (Foxo1KO) mice
of mixed C57BL/6 and FVB genetic backgrounds have been previously
described (Kerdiles et al., 2010). For other experiments, Foxo1f/f mice were
backcrossed to C57BL/6 (Jackson) for at least 13 generations and then
crossed to Rosa26Cre-ERT2, which had also been backcrossed to C57BL/6 for
10 generations, and OTII to generate backcrossed Foxo1f/fRosa26Cre-ERT2
and Foxo1f/f Rosa26Cre-ERT2 OTII mice. For additional controls, OTII mice
were crossed to CD45.1, or Rosa26Cre-ERT2 mice as indicated. Rosa26-
hFoxo1AAA (Foxo1AAA) (Ouyang et al., 2012) were bred to OT-II mice. Unless
otherwise indicated, CD45.1 mice were used as hosts for adoptive transfer ex-
periments. CD45.1 mice were purchased from Jackson Laboratories and
maintained in our colony. Foxo1f/fCd4Cre mice were crossed to B6.129P2-
ICOStm1Mak/J (Icos/) mice from Jackson Laboratories. Icosl/ host mice
were purchased fromJackson Laboratories andmaintained at La Jolla Institute
for Allergy and Immunology. Bone-marrow chimera experiments were carried
out at the University of Washington. The FOXO1-EGFP knock-in mice were
generated at Taconic as described in Supplemental Information.
Adoptive Transfer Experiments
For in vivo Tfh cell experiments in which mice were immunized, OTII cells were
enriched by negative magnetic selection for naive CD4 (CD69CD25CD4+)
cells and 0.1 to 0.5 3 106 OTII cells were adoptively transferred into CD45.1
hosts unless other indicated. Approximately 2 to 12 hr later, mice were immu-
nized intraperitoneally (i.p.) with 0.1 mg of OVA in 200 ml of Sigma Adjuvant
System (Sigma) as per manufacturer’s instructions. The phenotype of trans-
ferred splenocytes at indicated days post immunization was determined. Forexperiments plus or minus inhibitory ICOSL-specific antibody (Clone: HK5.3,
BioXCell) 100 mg of anti-ICOSL or isotype control were injected intravenously
(i.v.) and an additional 100 mg were injected i.p. immediately prior to immuniza-
tions. An additional 100 mg of the appropriate antibody was injected i.p. 2 dpi.
Where indicated, mice were infected with 10 3 106 cfu of DActA-Lm-OVA i.v.
For VSV-OVA co-transfer experiments, 10,000 cells of each WT OTII
(CD45.1.2) and Foxo1KO OTII (CD45.2) cells were transferred into the same
host mice and the next day mice were infected with 105 pfu of VSV-OVA.
Phenotype of transferred cells was determined 6–7 days post infection by
flow cytometry.
In Vitro ICOS Signaling Experiments
To study ICOS signaling, we activated and restimulated cells with anti-ICOS
similarly to previously described ICOS restimulation conditions (Rolf et al.,
2010a). Briefly, WT or FOXO1-GFP naive CD4 (CD69CD25CD4+) T cells
were purified by negative depletion and activated with anti-CD3 (2C11),
1 mg/ml anti-CD28 plus or minus 10 mg/ml anti-IFN-g, 10 mg/ml anti-IL-4,
50 ng/ml IL-6, and 10 ng/ml IL-21 (iTfh conditions) in RP10 for 48 hr. After
48 hr, the cells were rested in RP10 for 24 hr. Following the rest, the cells
were restimulated with soluble anti-CD3 0.5 mg/ml, goat anti-hamster
20 mg/ml (Vector Labs, Burlingame, CA) with or without stimulatory 2 mg/ml
anti-ICOS (Clone: C398.4A, eBioscience). To determine whether ICOS
signaling inactivated, we collected FOXO1 cells at 30 m or 24 hr post restim-
ulation and analyzed FOXO1-GFP compared to DRAQ5 staining using AMNIS
ImageStream and BD LSR Fortessa analysis. To determine whether ICOS
signaling through FOXO1 might be involved in ICOS upregulation of BCL6,
we left WT or Foxo1KO CD4 T cells in culture for 24 hr post restimulation and
analyzed expression of Tfh markers by flow cytometry.
Imaging Flow Cytometry
FOXO1-GFP localization was determined using the 603 objective on
ImageStreamX MkII (Amnis/EMD Millipore). FOXO1-GFP signal was
compared to the nuclear mask generated using signal from DRAQ5 (Cell
Signaling). Data was analyzed with IDEAS software including the nuclear local-
ization wizard. To determine percent of cells with cytoplasmic FOXO1-GFP,
we gated cells with a similarity score from FOXO1-GFP and DRAQ5 less
than the similarity score that was determined by visual examination of images
to represent cells is which FOXO1-GFP was excluded from the nucleus. The
nuclear intensity of FOXO1-GFP reflects the amount of FOXO1-GFP within
the DRAQ5 nuclear mask.
Generation, Infection, and Analysis of Mixed Bone-Marrow
Chimeras
Bone-marrow cells were harvested from femurs, tibias, and humeri. T cells
were depleted from bone-marrow cell suspensions with anti-Thy1.2 (30-
H12, eBioscience) and low-toxicity rabbit complement (Cedarlane Labora-
tories). CD45.1+ wild-type bone-marrow cells were mixed with 4-fold excess
CD45.2+ Foxo1TKO bone-marrow cells. 5–106 total bone-marrow cells were
injected into lethally irradiated (10 Gy) CD45.1.2+ hosts. Eight weeks later,
chimerism was assessed by flow cytometry and mice were injected intrave-
nously with 107 actA deficient Listeria monocytogenes (Lm) bacteria engi-
neered to secrete a fusion protein containing an immunogenic peptide (Lm-
2W) (Ertelt et al., 2009). Nine days later, mice were sacrificed, spleen and
lymph node cells were harvested, and lymphocytes were stained for 1 hr at
room temperature with LLOp:I-Ab-streptavidin-allophycocyanin tetramers
and 2mg of phycoerythrin-conjugated antibody specific for CXCR5 (2G8; Bec-
ton Dickinson). Samples were then enriched for bead-bound cells on magne-
tized columns (Moon et al., 2007). Cells were then analyzed by flow cytometry.
Statistical Analyses
Unless otherwise indicated two-tailed, unpaired Student t tests were used to
determine statistical significance. * p < 0.05, **p < 0.01, ***p < 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
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